Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma

World Journal of Gastroenterology

Volumn 7, Issue 4, 2001, Pages 500-505

  Liu, D H ^a   Zhang, X Y ^a   Fan, D M ^a   Huang, Y X ^a   Zhang, J S ^a   Huang, W Q ^a   Zhang, Y Q ^a   Huang, Q S ^a   Ma, W Y ^a   Chai, Y B ^a   Jin, M ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CELL SURFACE PROTEIN; DNA; MESSENGER RNA; PROTEIN KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER TISSUE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EUKARYOTIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRECANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SOLID TUMOR; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR VOLUME; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM;

EID: 0034882581     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i4.500     Document Type: Article

References (76)

1. What is the evidence that tumors are angiogenesis dependent?
2. Novel growth regulatory factors and tumour angiogenesis
3. Angiogenic factors
4. Basic fibroblast growth factor induces angiogenesis in vitro
5. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
6. Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer
7. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension
8. 121 in gastric carcinoma MGC803 cell line
9. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
10. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
11. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
12. Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant
13. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
14. Investigation of SGC-7901 cell line established from human gastric carcinoma cells
15. Lipofection: A highly efficient, lipid-mediated DNA/transfection procedure
16. Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse
17. Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice
18. Prevention of metastasis to liver by using 5-FU intraperitoneal chemotherapy in nude mice inoculated with human colonic cancer cells
19. Expression significance of mdr1 gene in gastric carcinoma tissue
20. Inhibition of telomerase activity of human liver cancer cell SMMC-7721 by chemotherapeutic drugs
21. Effect of chemotherapy or targeting chemotherapy on apoptosis of colorectal carcinoma
22. Significance of microvessel count in gastric carcinoma
23. Expression of vascular endothelial growth factor and its prognostic significance in gastric carcinoma
24. Morphological analysis of lymph vessels and capillaries in gastric carcinoma
25. Overproduction of nitric oxide inhibits vascular reactivity in portal hypertensive rats
26. Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes
27. Raf-1 protein kinase is required for growth of induced NIH3T3 cells
28. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum
29. Wild type P53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
30. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
31. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
32. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
33. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia
34. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
35. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
36. Prognostic value of vascular endothelial growth factor and its receptor flt-1 in squamous cell lung cancer
37. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression
38. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
39. A pathologic analysis of 4451 cases with digestive tract cancer
40. Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissues
41. Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients
42. Measurements of cell proliferation in esophageal and gastric cardia epithelia of subjects in a high incidence area for esophageal cancer
43. P53 and PCNA expression in glandular dilatation of gastric mucosa
44. Quantitative ultrastructure analysis of neuroendocrine cells of gastric mucosa in normal and pathological conditions
45. Ultrastructural enzyme cytochemical study on signet-ring cells of gastric cancer
46. Loss of heterozygosity and mRNA expression at DCC locus in gastric cancer
47. A preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers
48. Clinicopathologic risk factors and prognostic evaluation in hepatocellular carcinoma recurrence after surgery
49. CEA and AFP expression in human hepatoma cells transfected with antisense IGF-I gene
50. Current status of gene therapy in gastroenterology
51. Prospect of gastroenterology and hepatology in the next century
52. Tumor growth inhibition effect of hIL-6 on colon cancer cells transfected with the target gene by retroviral vector
53. Inhibitory effect of IGF-II antisense RNA on malignant phenotype of hepatocellular carcinoma
54. Anti-angiogenesis: New concept for therapy of solid tumors
55. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
56. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
57. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells
58. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro
59. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers
60. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities
61. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor
62. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors
63. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer
64. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor
65. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor
66. Vascular endothelial growth factor as a target for cancer gene therapy
67. Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas
68. Antiangiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo
69. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
70. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: Effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts
71. Adventitial gene transfer to arterial wall
72. Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma
73. Local drug delivery and gene therapy
74. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
75. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
76. VEGF-mediated tumour angiogenesis: A new target for cancer therapy